TY  - JOUR
T1  - The diagnostik value of eosinophil-to-lymphocyte ratio in predicting contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction
AU  - Karayiğit, Orhan
AU  - Gök, Murat
AU  - Balun, Ahmet
AU  - Kurtul, Alparslan
PY  - 2025
DA  - March
Y2  - 2025
DO  - 10.38053/acmj.1605520
JF  - Anatolian Current Medical Journal
JO  - Anatolian Curr Med J / ACMJ / acmj
PB  - MediHealth Academy Yayıncılık
WT  - DergiPark
SN  - 2718-0115
SP  - 120
EP  - 125
VL  - 7
IS  - 2
LA  - en
AB  - Aims: Inflammation is considered a major contributor to the development of contrast-induced nephropathy (CIN). The purpose of this study was to assess the effectiveness of eosinophil-to-lymphocyte ratio (ELR) as a predictor of CIN among patients who experienced percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). Methods: The study involved 440 patients diagnosed with STEMI who underwent primary PCI. The participants were categorized into two classes based on whether they had CIN or not. ELR was calculated by dividing the eosinophil count by the lymphocyte count.  Results: The group with CIN (+) showed significantly higher ELR levels (0.134±0.063 vs. 0.069±0.037, p
KW  - Eosinophil-to-lymphocyte ratio
KW  - contrast-induced nephropathy
KW  - percutaneous coronary intervention
KW  - ST-segment 
elevation myocardial infarction
CR  - Elserafy AS, Okasha N, Hegazy T. Prevention of contrast induced nephropathy by ischemic preconditioning in patients undergoing percutaneous coronary angiography. Egypt Heart J. 2018;70(2):107-111. doi:10.1016/j.ehj.2017.12.004
CR  - Moro AB, Strauch JGN, Groto AD, Toregeani JF. Creatinine level variation in patients subjected to contrast-enhanced tomography: a meta-analysis. J Vasc Bras. 2021;20:e20200161. doi:10.1590/1677-5449. 200161
CR  - Moitinho MS, Santos ES, Caixeta AM, Belasco AGDS, Barbosa DA, Fonseca CDD. Contrast-induced nephropathy in patients submitted to percutaneous coronary intervention: an integrative review. Rev Bras Enferm. 2020;73(suppl 5):e20200190. doi:10.1590/0034-7167-2020-0190
CR  - Brar SS, Aharonian V, Mansukhani P, et al. Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial. Lancet. 2014;383(9931):1814-1823. doi:10.1016/S0140-6736(14)60689-9
CR  - Kwasa EA, Vinayak S, Armstrong R. The role of inflammation in contrast-induced nephropathy. Br J Radiol. 2014;87(1041):20130738. doi: 10.1259/bjr.20130738
CR  - Wang JG, Mahmud SA, Thompson JA, Geng JG, Key NS, Slungaard A. The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood. 2006;107(2):558-565. doi:10.1182/blood-2005-05-2152
CR  - Horne BD, Anderson JL, John JM, et al. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol. 2005;45(10): 1638-1643. doi:10.1016/j.jacc.2005.02.054
CR  - Kounis NG, Soufras GD, Tsigkas G, Hahalis G. White blood cell counts, leukocyte ratios, and eosinophils as inflammatory markers in patients with coronary artery disease. Clin Appl Thromb Hemost. 2015;21(2):139-143. doi:10.1177/1076029614531449
CR  - Vural A, Aydın E. The predictive value of eosinophil indices for major cardiovascular events in patients with acute decompensated HFrEF. Medicina (Kaunas). 2022;58(10):1455. doi:10.3390/medicina58101455
CR  - Vavalle JP, van Diepen S, Clare RM, et al. Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: predictors, clinical and angiographic features, and outcomes. Am Heart J. 2016;173:57-66. doi:10.1016/j.ahj.2015.12.001
CR  - Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2): 119-177. doi:10.1093/eurheartj/ehx393
CR  - Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate [published correction appears in Ann Intern Med. 2011;155(6):408]. Ann Intern Med. 2009;150(9):604-612. doi:10. 7326/0003-4819-150-9-200905050-00006
CR  - Senoo T, Motohiro M, Kamihata H, et al. Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010;105(5):624-628. doi:10. 1016/j.amjcard.2009.10.044
CR  - Butt K, D'Souza J, Yuan C, et al. Correlation of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) with contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary interventions. Cureus. 2020;12(12):e11879. doi:10.7759/cureus.11879
CR  - Zhang F, Lu Z, Wang F. Advances in the pathogenesis and prevention of contrast-induced nephropathy. Life Sci. 2020;259:118379. doi:10.1016/j.lfs.2020.118379
CR  - Lu Z, Cheng D, Yin J, et al. Antithrombin III protects against contrast-induced nephropathy. EBioMedicine. 2017;17:101-107. doi:10.1016/j.ebiom.2017.02.009
CR  - Ramirez GA, Yacoub MR, Ripa M, et al. Eosinophils from physiology to disease: a comprehensive review. Biomed Res Int. 2018;2018:9095275. doi:10.1155/2018/9095275
CR  - Colon S, Luan H, Liu Y, Meyer C, Gewin L, Bhave G. Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model. Am J Physiol Renal Physiol. 2019;316(2):F360-F371. doi:10.1152/ajprenal.00291.2018
CR  - Kielar D, Jones AM, Wang X, et al. Association between elevated blood eosinophils and chronic kidney disease progression: analyses of a large United States electronic health records database. Int J Nephrol Renovasc Dis. 2023;16:269-280. doi:10.2147/IJNRD.S431375
CR  - Widmer A, Linka AZ, Attenhofer Jost CH, et al. Mechanical complications after myocardial infarction reliably predicted using C-reactive protein levels and lymphocytopenia. Cardiology. 2003;99(1): 25-31. doi:10.1159/000068448
CR  - Núñez J, Miñana G, Bodí V, et al. Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18(21):3226-3233. doi:10. 2174/092986711796391633
CR  - Holub K, Biete A. New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer. BMC Cancer. 2018;18(1):1280. doi:10.1186/s12885-018-5131-x
CR  - Yilmaz M, Kayançiçek H, Korkmaz H, et al. A new inflammatory marker: elevated eosinophil-tolymphocyte ratio associated with presence and severity of isolated coronary artery ectasia. Cardiovasc J Afr. 2020;31(5):227-235. doi:10.5830/CVJA-2019-049
CR  - Çetin ZG, Demirtaş B. Understanding the significance of the eosinophil to lymphocyte ratio in individuals with microvascular angina. Bozok Tıp Derg. 2023;13(3):73-80. doi:10.16919/bozoktip.1341814
CR  - Tosu AR, Kalyoncuoğlu M, Biter Hİ, et al. Association of eosinophil-to-lymphocyte ratio with coronary slow-flow phenomenon in patients undergoing coronary angiography. Arch Med Sci Atheroscler Dis. 2022; 7(1):e29-e35. doi:10.5114/amsad.2022.116662
UR  - https://doi.org/10.38053/acmj.1605520
L1  - https://dergipark.org.tr/tr/download/article-file/4459029
ER  -